In vitro metabolism of 8-2 fluorotelomer alcohol: interspecies comparisons and metabolic pathway refinement.

The detection of perfluorinated organic compounds in the environment has generated interest in their biological fate. 8-2 Fluorotelomer alcohol (8-2 FTOH, C(7)F(15)CF(2)CH(2)CH(2)OH), a raw material used in the manufacture of fluorotelomer-based products, has been identified in the environment and has been implicated as a potential source for perfluorooctanoic acid (PFOA) in the environment. In this study, the in vitro metabolism of [3-(14)C] 8-2 FTOH and selected acid metabolites by rat, mouse, trout, and human hepatocytes and by rat, mouse, and human liver microsomes and cytosol were investigated. Clearance rates of 8-2 FTOH in hepatocytes indicated rat > mouse > human >/= trout. A number of metabolites not previously reported were identified, adding further understanding to the pathway for 8-2 FTOH metabolism. Neither perfluorooctanoate nor perfluorononanoate was detected from incubations with human microsomes. To further elucidate the steps in the metabolic pathway, hepatocytes were incubated with 8-2 fluorotelomer acid, 8-2 fluorotelomer unsaturated acid, 7-3 acid, 7-3 unsaturated acid, and 7-2 secondary fluorotelomer alcohol. Shorter chain perfluorinated acids were only observed in hepatocyte and microsome incubations of the 8-2 acids but not from the 7-3 acids. Overall, the results indicate that 8-2 FTOH is extensively metabolized in rats and mice and to a lesser extent in humans and trout. Metabolism of 8-2 FTOH to perfluorinated acids was extremely small and likely mediated by enzymes in the microsomal fraction. These results suggest that human exposure to 8-2 FTOH is not expected to be a significant source of PFOA or any other perfluorocarboxylic acids.

[1]  B. Fleshler,et al.  The Liver: Biology and Pathobiology , 1983 .

[2]  M. Andersen,et al.  A physiologically based toxicokinetic model for the uptake and disposition of waterborne organic chemicals in fish. , 1990, Toxicology and applied pharmacology.

[3]  J. Klaunig,et al.  Trout hepatocyte culture: Isolation and primary culture , 1985, In Vitro Cellular & Developmental Biology.

[4]  J. Bierau,et al.  Metabolic inactivation of five glycidyl ethers in lung and liver of humans, rats and mice in vitro , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  A. L. Mendrala,et al.  Rapid uptake, metabolism, and elimination of inhaled sulfuryl fluoride fumigant by rats. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  Konstantinos Prevedouros,et al.  Sources, Fate and Transport of Perfluorocarboxylates , 2006 .

[7]  J. J. Baran.  Fluorinated Surfactants and Repellents: Second Edition, Revised and Expanded Surfactant Science Series. Volume 97. By Erik Kissa (Consultant, Wilmington, DE). Marcel Dekker: New York. 2001. xiv + 616 pp. $195.00. ISBN 0-8247-0472-X. , 2001 .

[8]  J. A. Bond,et al.  Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. , 1992, Carcinogenesis.

[9]  P. Seglen.  Preparation of isolated rat liver cells. , 1976, Methods in cell biology.

[10]  I. Skånberg,et al.  Cytochrome P-450-dependent oxidation of felodipine--a 1,4-dihydropyridine--to the corresponding pyridine. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  A. Li,et al.  Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[12]  R. Haynes,et al.  Structure-activity relationships for growth inhibition and induction of apoptosis by 4-hydroxy-2-nonenal in raw 264.7 cells. , 2000, Molecular pharmacology.

[13]  J. A. Bond,et al.  In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data. , 1994, Carcinogenesis.

[14]  Ning Wang,et al.  Aerobic biotransformation of 14C-labeled 8-2 telomer B alcohol by activated sludge from a domestic sewage treatment plant. , 2005, Environmental science & technology.

[15]  I Skånberg,et al.  In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man. , 2009, Acta pharmacologica et toxicologica.

[16]  P. Seglen.  Preparation of rat liver cells. I. Effect of Ca 2+ on enzymatic dispersion of isolated, perfused liver. , 1972, Experimental cell research.

[17]  E. Mylchreest,et al.  Evaluation of the Developmental Toxicity of 8-2 Telomer B Alcohol , 2005, Drug and chemical toxicology.

[18]  S. Mabury,et al.  Perfluoroalkyl contaminants in a food web from Lake Ontario. , 2004, Environmental science & technology.

[19]  Ning Wang,et al.  Fluorotelomer alcohol biodegradation-direct evidence that perfluorinated carbon chains breakdown. , 2005, Environmental science & technology.

[20]  Robert C Buck,et al.  Absorption, distribution, metabolism, and elimination of 8-2 fluorotelomer alcohol in the rat. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[21]  G. Ladics,et al.  Subchronic Toxicity of a Fluoroalkylethanol Mixture in Rats , 2005, Drug and chemical toxicology.

[22]  Scott A Mabury,et al.  Metabolic products and pathways of fluorotelomer alcohols in isolated rat hepatocytes. , 2005, Chemico-biological interactions.

[23]  Tony Cox,et al.  The Impact of Cytochrome P450 2E1‐Dependent Metabolic Variance on a Risk‐Relevant Pharmacokinetic Outcome in Humans , 2003, Risk analysis : an official publication of the Society for Risk Analysis.

[24]  A. Calafat,et al.  Perfluorochemicals in pooled serum samples from United States residents in 2001 and 2002. , 2006, Environmental science & technology.

[25]  Derek C G Muir,et al.  Biological monitoring of polyfluoroalkyl substances: A review. , 2006, Environmental science & technology.

[26]  Timothy J Wallington,et al.  Degradation of fluorotelomer alcohols: a likely atmospheric source of perfluorinated carboxylic acids. , 2004, Environmental science & technology.

[27]  L. Teuschler,et al.  Variance of Microsomal Protein and Cytochrome P450 2E1 and 3A Forms in Adult Human Liver , 2003, Toxicology mechanisms and methods.

[28]  E. Kissa,et al.  Fluorinated Surfactants and Repellents , 2001 .

[29]  M. Delp,et al.  Physiological Parameter Values for Physiologically Based Pharmacokinetic Models , 1997, Toxicology and industrial health.

[30]  M. Chiba,et al.  Pharmacokinetic correlation between in vitro hepatic microsomal enzyme kinetics and in vivo metabolism of imipramine and desipramine in rats. , 1990, Journal of pharmaceutical sciences.

[31]  C. Kennedy,et al.  A biologically based toxicokinetic model for pyrene in rainbow trout. , 1991, Toxicology and applied pharmacology.

[32]  Yoshihiro Yamakawa,et al.  Induction of hepatic peroxisome proliferation by 8-2 telomer alcohol feeding in mice: formation of perfluorooctanoic acid in the liver. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[33]  Neil Kaplowitz,et al.  Liver biology and pathobiology , 2006, Hepatology.

[34]  R. Obach,et al.  Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[35]  E. Cadenas,et al.  Effects of 4-hydroxynonenal on isolated hepatocytes. Studies on chemiluminescence response, alkane production and glutathione status. , 1983, The Biochemical journal.

[36]  J B Houston,et al.  Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. , 1994, Biochemical pharmacology.

[37]  J. Joly,et al.  Cytochrome P-450 measurement in rat liver homogenate and microsomes. Its use for correction of microsomal losses incurred by differential centrifugation. , 1975, Drug metabolism and disposition: the biological fate of chemicals.